ACOG

Alpha Cognition Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$8.56

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %2 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %8.4 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.

Website

Analysis (Turkish): ACOG Hissesi Caiz mi, Helal mi? Alpha Cognition Inc. Katılım Analizi